Trabecular Reorganization in Consecutive Iliac Crest Biopsies when Switching from Bisphosphonate to Strontium Ranelate Treatment

Abstract

BackgroundSeveral agents are available to treat osteoporosis while addressing patient-specific medical needs. Individuals' residual risk to severe fracture may require changes in treatment strategy. Data at osseous cellular and microstructural levels due to a therapy switch between agents with different modes of action are rare. Our study on a series of five consecutively taken bone biopsies from an osteoporotic individual over a six-year period analyzes changes in cellular characteristics, bone microstructure and mineralization caused by a therapy switch from an antiresorptive (bisphosphonate) to a dual action bone agent (strontium ranelate).Methodology/Principal FindingsBiopsies were progressively taken from the iliac crest of a female patient. Four biopsies were taken during bisphosphonate therapy and one biopsy was taken after one year of strontium ranelate (SR) treatment. Furthermore, serum bone markers and dual x-ray absorptiometry measurements were acquired. Undecalcified histology was used to assess osteoid parameters and bone turnover. Structural indices and degree of mineralization were determined using microcomputed tomography, quantitative backscattered electron imaging, and combined energy dispersive x-ray/µ-x-ray-fluorescence microanalysis.Conclusions/SignificanceMicrostructural data revealed a notable increase in bone volume fraction after one year of SR treatment compared to the bisphosphonate treatment period. Indices of connectivity density, structure model index and trabecular bone pattern factor were predominantly enhanced indicating that the architectural transformation from trabecular rods to plates was responsible for the bone volume increase and less due to changes in trabecular thickness and number. Administration of SR following bisphosphonates led to a maintained mineralization profile with an uptake of strontium on the bone surface level. Reactivated osteoclasts designed tunneling, hook-like intratrabecular resorption sites. The appearance of tunneling resorption lacunae and the formation of both mini-modeling units and osteon-like structures within increased plate-like cancellous bone mass provides additional information on the mechanisms of strontium ranelate following bisphosphonate treatment, which may deserve special attention when monitoring a treatment switch.

The incorporation of fluoride and strontium in hydroxyapatite affects the composition, structure, and mechanical properties of human cortical bone

“…Some individuals received a treatment with BPs prior to the treatment with strontium ranelate resulting in an increased heterogeneity of the group. However, several studies were able to observe changes, for example, in the microstructure of bone induced by the strontium administration following a BP treatment . A study on human cortical bone revealed that RPI values (i.e.…”

“…However, several studies were able to observe changes, for example, in the microstructure of bone induced by the strontium administration following a BP treatment. 14,54 A study on human cortical bone revealed that RPI values (i.e. ID 1st, IDI, and TID) did not significantly change after BP treatment in osteoporosis, but tended to be higher compared to treatment-na€ ıve osteoporosis cases.…”

Change in Bone Mineral Density with Strontium Citrate: An Illusion or Reality

“…Histiomorphic and CT analyses of bone show improved bone mass, volume, microarchitecture and strength following SrR supplementation [7,[10][11][12][13]. Its effects are seen more on trabecular bone than cortical bone [9].…”

Analysis of retrieved hip resurfacing arthroplasties reveals the interrelationship between interface hyperosteoidosis and demineralization of viable bone trabeculae

“…BMDD was measured on plastic embedded cross‐sections of the femoral head with a polished and carbon‐coated surface using qBEI 30–36. The scanning electron microscope (LEO 435 VP, LEO Electron Microscopy Ltd., Cambridge, England) was operated at 15 kV and 665 pA at a constant working distance (BSE Detector, Type 202, K.E.…”